×
About 673 results

ALLMedicine™ Superior Vena Cava Syndrome Center

Research & Reviews  250 results

Melanoma of unknown primary origin with skeletal muscle metastasis: a case report.
https://doi.org/10.1186/s13256-023-03813-4
Journal of Medical Case Reports; Andrianandrasana NOTF, Randrianarisoa RMF et. al.

Mar 13th, 2023 - Melanoma is usually discovered from an irregular skin patch or a modification of a preexisting patch. Cutaneous and lymph node metastases are common. Muscle metastases are rare. We report a case of melanoma with infiltration of the gluteus maximus...

Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the ...
https://doi.org/10.1002/jcsm.13216
Journal of Cachexia, Sarcopenia and Muscle; Shukuya T, Takahashi K et. al.

Mar 12th, 2023 - Cancer cachexia is a syndrome that does not fully recover with nutritional support and causes appetite loss and body weight loss. It worsens a patient's quality of life and prognosis. In this study, the epidemiology of cachexia in lung cancer, its...

Substernal multinodular goiter resulting in superior vena cava syndrome and tracheal co...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980338
BMJ Case Reports; Gorniak A, Carlson-Dexter P et. al.

Mar 2nd, 2023 - A woman in her early 70s presented to the family medicine clinic with shortness of breath and an inability to lie flat for several months. When lying flat or on lifting her arms above her head, her face would turn bright red and she felt lighthead...

Collateral Vascularization in Chronic Superior Vena Cava Syndrome.
https://doi.org/10.1016/j.mayocp.2022.10.005
Mayo Clinic Proceedings; Black AK, Tom MC

Feb 4th, 2023 - Collateral Vascularization in Chronic Superior Vena Cava Syndrome.|2023|Black AK,Tom MC,|diagnosis,etiology,

Clinical Impact of Thoracic Scanographic Characteristics of Hematologic Malignancy Patients
https://clinicaltrials.gov/ct2/show/NCT05694806

Jan 23rd, 2023 - The mediastinum can be the site of benign or malignant tumors, including 10 to 20% of hematological malignancies. Mediastinal mass syndrome (MMS) includes symptoms due to irritation, invasion or compression of the organs of the mediastinum. This s...

see more →

Clinicaltrials.gov  2 results

Clinical Impact of Thoracic Scanographic Characteristics of Hematologic Malignancy Patients
https://clinicaltrials.gov/ct2/show/NCT05694806

Jan 23rd, 2023 - The mediastinum can be the site of benign or malignant tumors, including 10 to 20% of hematological malignancies. Mediastinal mass syndrome (MMS) includes symptoms due to irritation, invasion or compression of the organs of the mediastinum. This s...

Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC
https://clinicaltrials.gov/ct2/show/NCT00561054

Nov 20th, 2007 - Criteria for inclusion Signed written informed consent Male or female ≥18 years of age Cito-histological diagnosis of NSCLC, stage IV Performance Status = 0 or 1 Measurable disease on CT scan - RECIST criteria White blood count ≥ 3 x 109/L, Neutro...

see more →

News  15 results

Increasing fatigue and dry cough
https://www.mdedge.com/lung-cancer-challenge-center/article/260343/lung-cancer/increasing-fatigue-and-dry-cough

Dec 22nd, 2022 - This patient's clinical presentation is consistent with a diagnosis of superior vena cava syndrome (SVCS), secondary to SCLC. SCLC is an aggressive, poorly differentiated, high-grade neuroendocrine carcinoma that accounts for approximately 13%-15%.

Clinical Presentation of Squamous NSCLC
https://www.onclive.com/view/clinical-presentation-of-squamous-nsclc

Apr 2nd, 2021 - Transcript:Benjamin Levy, MD: Hello, and thank you for joining us for this OncLive Peer Exchange. Until recently, little progress had been made in the area of squamous non-small cell lung cancer. Now, with the excitement of recent positive trials ...

Novel Molecular Targets for Drug Development in Non-GIST Sarcomas
https://www.onclive.com/view/novel-molecular-targets-for-drug-development-in-non-gist-sarcomas

Dec 20th, 2020 - William D. Tap, MD Abstract The characterization of molecular abnormalities implicated in the tumorigenesis of sarcomas is being increasingly applied to the classification, prognostication and, in particular situations, management of these ...

From a Distance: Managing Side Effects in Outpatients
https://www.onclive.com/view/from-a-distance-managing-side-effects-in-outpatients

Dec 5th, 2020 - Oncology nurses know the intricacies of cancer treatment. They know how to interact with patients in distress. And they know how to handle long-distance relationships. It is a skill nurses have developed in the past 10 years, as cancer treatment h...

Untreated Goiters Larger at Surgery in Men, Minorities, and the Old
https://www.staging.medscape.com/viewarticle/860299

Mar 14th, 2016 - Significant disparities exist in the presentation and outcomes of patients with goiters in the United States, with minority ethnic groups, men, and older patients more likely to present with untreated goiters that have become so large they extend ...

see more →

Patient Education  2 results see all →